3-rx.comCustomer Support
3-rx.com
   
HomeAbout UsFAQContactHelp
News Center
Health Centers
Medical Encyclopedia
Drugs & Medications
Diseases & Conditions
Medical Symptoms
Med. Tests & Exams
Surgery & Procedures
Injuries & Wounds
Diet & Nutrition
Special Topics



\"$alt_text\"');"); } else { echo"\"$alt_text\""; } ?>


Join our Mailing List





Syndicate

You are here : 3-RX.com > Home > Cancer -

Histochemistry is the golden standard in the diagnosis of carcinosarcomas

CancerNov 15, 07

A case study of carcinosarcoma has been published in the World Journal of Gastroenterology on November 7, 2007. The patient in the study was the first case of gastric carcinosarcoma obtained in this part of the world . The patient was admitted by Dr. Tomislav Randjelovic as surgeon and Dr. Branka Filipovic as gastroenterologist. The operation was performed by Dr. Randjelovic and his team; the anatomical and patoanatomical evaluation of macroscopic and microscopic features of the tumor were performed by Dr. Babic, Dr. Cemerikic and Dr. Filipovic.

Carcinosarcomas are very rare malignancies in the Western Balkans.

Moreover, our case is, to the best of our knowledge, the first ever reported . It is important never to reject the possibility of the appearance of carcinosarcoma in differential diagnosis of the clinical manifestations described in our paper, which appeared to be unspecific and could potentially be connected with numerous diseases of the stomach.

Their case shows that histochemistry is the golden standard in the diagnosis of carcinosarcomas: epithelial component expressed positivity for cytokeratin 18, epithelial membranous antigen (EMA), and carcinoembryonic antigen (CEA). Chromogranin A positive epithelial cells could also be observed. The mesenchymal component had intensive staining for vimentin, although neither muscular nor neural differentiation could be found. No Helicobacter pylori was seen.

###


About World Journal of Gastroenterology

World Journal of Gastroenterology (WJG), a leading international journal in gastroenterology and hepatology, has established a reputation for publishing first class research on esophageal cancer, gastric cancer, liver cancer, viral hepatitis, colorectal cancer, and H pylori infection for providing a forum for both clinicians and scientists. WJG has been indexed and abstracted in Current Contents/Clinical Medicine, Science Citation Index Expanded (also known as SciSearch) and Journal Citation Reports/Science Edition, Index Medicus, MEDLINE and PubMed, Chemical Abstracts, EMBASE/Excerpta Medica, Abstracts Journals, Nature Clinical Practice Gastroenterology and Hepatology, CAB Abstracts and Global Health. ISI JCR 2003-2000 IF: 3.318, 2.532, 1.445 and 0.993. WJG is a weekly journal published by WJG Press. The publication dates are the 7th, 14th, 21st, and 28th day of every month. The WJG is supported by The National Natural Science Foundation of China, No. 30224801 and No. 30424812, and was founded with the name of China National Journal of New Gastroenterology on October 1, 1995, and renamed WJG on January 25, 1998.

About The WJG Press

The WJG Press mainly publishes World Journal of Gastroenterology

Contact: You-De Chang
.(JavaScript must be enabled to view this email address)
86-108-538-1892
World Journal of Gastroenterology



Print Version
Tell-a-Friend
comments powered by Disqus

RELATED ARTICLES:
  New biomarkers may influence drug design and alternative treatments of cancer, study shows
  Metabolic profiles distinguish early stage ovarian cancer with unprecedented accuracy
  Moffitt researchers develop first genetic test to predict tumor sensitivity to radiation therapy
  New drug for neuroblastoma shows promise in phase I study
  Experimental treatment sends deadly leukemia into remission
  Study could reduce unnecessary cancer screening
  UA researchers discover component of cinnamon prevents colorectal cancer in mice
  Profiling approach to enable right lung cancer treatment match
  Fat grafting technique improves results of breast augmentation
  Germline TP53 mutations in patients with early-onset colorectal cancer
  Clinical trial suggests combination therapy is best for low-grade brain tumors
  UW research shows sensor technology may help improve accuracy of clinical breast exams

 












Home | About Us | FAQ | Contact | Advertising Policy | Privacy Policy | Bookmark Site